← Back to headlines
H.C. Wainwright Reduces Price Goal on Summit Therapeutics Inc.
H.C. Wainwright has lowered its price target for Summit Therapeutics Inc. (SMMT) stock.
13 May, 17:53 — 13 May, 17:53
Sources
Showing 1 of 1 sources
Related Stories
Fed’s Waller Signals Potential September Rate Pause, Markets Rally
56m ago
Netherlands Transfers Billions in Gold Reserves From U.S. to London
4h ago
Jet2 Upgrades to London Stock Exchange Main Market After Strong Summer
7h ago
Swiss Economy Hits Five-Year Growth High as Inflation Rises to 0.8 Percent
14h ago